Cargando…
Lipogenic effects of androgen signaling in normal and malignant prostate
Prostate cancer is an androgen-dependent cancer with unique metabolic features compared to many other solid tumors, and typically does not exhibit the “Warburg effect”. During malignant transformation, an early metabolic switch diverts the dependence of normal prostate cells on aerobic glycolysis fo...
Autores principales: | Mah, Chui Yan, Nassar, Zeyad D., Swinnen, Johannes V., Butler, Lisa M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Second Military Medical University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7385522/ https://www.ncbi.nlm.nih.gov/pubmed/32742926 http://dx.doi.org/10.1016/j.ajur.2019.12.003 |
Ejemplares similares
-
Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer
por: Hinneh, Josephine A., et al.
Publicado: (2023) -
Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis
por: Nassar, Zeyad D, et al.
Publicado: (2020) -
Evaluation of androgen-induced effects on the uptake of [(18)F]FDG, [(11)C]choline and [(11)C]acetate in an androgen-sensitive and androgen-independent prostate cancer xenograft model
por: Emonds, Kimy M, et al.
Publicado: (2013) -
Lipogenic signalling modulates prostate cancer cell adhesion and migration via modification of Rho GTPases
por: De Piano, Mario, et al.
Publicado: (2020) -
Lipogenic metabolism: a viable target for prostate cancer treatment?
por: Liang, Mengmeng, et al.
Publicado: (2014)